Comparative cost analysis of HCVST and PL-HCVT models (in US$). by Bao Vu Ngoc (14551955)

Subjects:

Incremental costs per month for different HCV testing models. by Bao Vu Ngoc (14551955)

Subjects:

Comparative costs of HCVST and PL-HCVT models in sensitivity analysis (in US$). by Bao Vu Ngoc (14551955)

Subjects:

HCV positivity rate by key population group opting for HCVST and standard HCVT. by Bao Vu Ngoc (14551955)

Subjects:

Factors associated with first-time HCV testing. by Bao Vu Ngoc (14551955)

Subjects:

Demographic characteristics of study participants. by Bao Vu Ngoc (14551955)

Subjects:

Proportion of first-time HCV testers by testing model. by Bao Vu Ngoc (14551955)

Subjects:

An <i>In Situ</i> TEM Study of the Diffusivity of Gold Atoms in Nanocomposite Thin Films by Zirconia Co-Deposition: Implication for Neuromorphic Devices by Alberto Casu (1285227)

Subjects:

An <i>In Situ</i> TEM Study of the Diffusivity of Gold Atoms in Nanocomposite Thin Films by Zirconia Co-Deposition: Implication for Neuromorphic Devices by Alberto Casu (1285227)

Subjects:

An <i>In Situ</i> TEM Study of the Diffusivity of Gold Atoms in Nanocomposite Thin Films by Zirconia Co-Deposition: Implication for Neuromorphic Devices by Alberto Casu (1285227)

Subjects:

An <i>In Situ</i> TEM Study of the Diffusivity of Gold Atoms in Nanocomposite Thin Films by Zirconia Co-Deposition: Implication for Neuromorphic Devices by Alberto Casu (1285227)

Subjects:

An <i>In Situ</i> TEM Study of the Diffusivity of Gold Atoms in Nanocomposite Thin Films by Zirconia Co-Deposition: Implication for Neuromorphic Devices by Alberto Casu (1285227)

Subjects:

An <i>In Situ</i> TEM Study of the Diffusivity of Gold Atoms in Nanocomposite Thin Films by Zirconia Co-Deposition: Implication for Neuromorphic Devices by Alberto Casu (1285227)

Subjects:

An <i>In Situ</i> TEM Study of the Diffusivity of Gold Atoms in Nanocomposite Thin Films by Zirconia Co-Deposition: Implication for Neuromorphic Devices by Alberto Casu (1285227)

Subjects:

This is the raw data used for this study. by James M. Friedman (22522150)

“…Average age was 48. 37% were male. 89% of patients who received a preoperative subcoracoid injection reported a significant decrease in presenting symptoms. 6 months after PM release, median VAS pain scores decreased from 8 to 2. …”

Pre-operative versus post-operative symptoms. by James M. Friedman (22522150)

“…Average age was 48. 37% were male. 89% of patients who received a preoperative subcoracoid injection reported a significant decrease in presenting symptoms. 6 months after PM release, median VAS pain scores decreased from 8 to 2. …”

Patient Demographics. by James M. Friedman (22522150)

“…Average age was 48. 37% were male. 89% of patients who received a preoperative subcoracoid injection reported a significant decrease in presenting symptoms. 6 months after PM release, median VAS pain scores decreased from 8 to 2. …”

Diagnostic Criteria for Human Disharmony Loop. by James M. Friedman (22522150)

“…Average age was 48. 37% were male. 89% of patients who received a preoperative subcoracoid injection reported a significant decrease in presenting symptoms. 6 months after PM release, median VAS pain scores decreased from 8 to 2. …”

Irradiation effect on <i>D. melanogaster</i> male courtship time in “no-choice” condition. GLM model values are shown. Values in boldface indicate significant differences. <i>D. su... by Flavia Cerasti (21655934)

Subjects:

Irradiation effect on <i>D. melanogaster</i> male courtship time in “choice” condition. GLM model values are shown. Values in boldface indicate significant differences. <i>D. suz</... by Flavia Cerasti (21655934)

Subjects: